2370013-49-1 (DZD9008,(S)-Sunvozertinib)

2-Propenamide, N-[5-[[4-[[5-chloro-4-fluoro-2-(1-hydroxy-1-methylethyl)phenyl]amino]-2-pyrimidinyl]amino]-2-[(3S)-3-(dimethylamino)-1-pyrrolidinyl]-4-methoxyphenyl]-;(S)-Sunvozertinib;MS-30455;SCHEMBL21232083;US11896597, Compound 76;N-[5-[[4-[5-chloro-4-fluoro-2-(2-hydroxypropan-2-yl)anilino]pyrimidin-2-yl]amino]-2-[(3S)-3-(dimethylamino)pyrrolidin-1-yl]-4-methoxyphenyl]prop-2-enamide;GLXC-25828;CS-0375228;2370013-49-1;(S)-DZD9008;DZD9008(N-[5-[[4-[5-Chloro-4-fluoro-2-(2-hydroxypropan-2-yl)anilino]pyrimidin-2-yl]amino]-2-[(3S)-3-(dimethylamino)pyrrolidin-1-yl]-4-methoxyphenyl]prop-2-enamide);N-{5-[(4-{[5-chloro-4-fluoro-2-(2-hydroxypropan-2-yl)phenyl]amino}pyrimidin-2-yl)amino]-2-[(3S)-3-(dimethylamino)pyrrolidin-1-yl]-4-methoxyphenyl}prop-2-enamide;BDBM536959;HY-132842A;EX-A5299;AC-35186;US11896597, Compound 87;(S)-DZD9008;DZD9008;AKOS040759768;(S)-Sunvozertinib?;DA-69275;

BTMKEDDEMKKSEF-KRWDZBQOSA-N

1S/C29H35ClFN7O3/c1-7-27(39)34-22-14-23(25(41-6)15-24(22)38-11-9-17(16-38)37(4)5)35-28-32-10-8-26(36-28)33-21-13-19(30)20(31)12-18(21)29(2,3)40/h7-8,10,12-15,17,40H,1,9,11,16H2,2-6H3,(H,34,39)(H2,32,33,35,36)/t17-/m0/s1

ClC1=C(C([H])=C(C(=C1[H])N([H])C1C([H])=C([H])N=C(N=1)N([H])C1=C(C([H])=C(C(=C1[H])N([H])C(C([H])=C([H])[H])=O)N1C([H])([H])C([H])([H])[C@@]([H])(C1([H])[H])N(C([H])([H])[H])C([H])([H])[H])OC([H])([H])[H])C(C([H])([H])[H])(C([H])([H])[H])O[H])F